Yahoo
HKSE - Delayed Quote HKD

ClouDr Group Limited (9955.HK)

0.400 0.000 (0.00%)
At close: November 6 at 4:08:50 PM GMT+8
Chart Range Bar
Loading chart for 9955.HK
  • Previous Close 0.400
  • Open 0.395
  • Bid 0.415 x --
  • Ask 0.420 x --
  • Day's Range 0.380 - 0.420
  • 52 Week Range 0.355 - 1.280
  • Volume 995,500
  • Avg. Volume 221,204
  • Market Cap (intraday) 258.288M
  • Beta (5Y Monthly) 0.32
  • PE Ratio (TTM) --
  • EPS (TTM) -0.730
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 1.82
  • Moby Rating Neutral

ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company's integrated in-hospital solution offers an AI-driven extensive hospital SaaS to assist doctors in diagnosis and treatment, and to help enhance the doctor education; chronic condition management solution to hospitals, including hospital SaaS and proprietary artificial intelligence of things devices. It also offers pharmacy SaaS, which enables in-store, real-time online consultation, prescription, and risk pooling of outpatient services; and sells chronic condition related drugs based on its data insights in pharmacies, including information on inventory, sales, and shipments of prescription drugs. In addition, the company provides integrated in-and out-of-hospital solutions that connect hospitals and pharmacies; insurance brokerage and advertisement agent services; and sells pharmaceuticals, consumables, medical devices, and miscellaneous, as well as chronic condition related drugs. Further, it offers internet and e-commerce services; distributes insurance products; and produces and sells pharmaceutical products. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.

www.cloudr.cn

776

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

9955.HK
59.60%
HANG SENG INDEX (^HSI)
4.48%

1-Year Return

9955.HK
64.91%
HANG SENG INDEX (^HSI)
7.57%

3-Year Return

9955.HK
94.18%
HANG SENG INDEX (^HSI)
36.26%

5-Year Return

9955.HK
98.69%
HANG SENG INDEX (^HSI)
1.56%

Analyst Insights

View More

Analyst Price Targets

1.82
1.82 Average
0.400 Current
1.82 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -29.77%

  • Return on Assets (ttm)

    -0.66%

  • Return on Equity (ttm)

    -57.66%

  • Revenue (ttm)

    1.36B

  • Net Income Avi to Common (ttm)

    -404.85M

  • Diluted EPS (ttm)

    -0.730

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    442.74M

  • Total Debt/Equity (mrq)

    127.02%

  • Levered Free Cash Flow (ttm)

    174.98M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: